Batysheva T.T., Bykova O.V., Vinogradov A.V. Cerebral palsy-modern ideas about the problem. Rossiyskiy meditsinskiy zhurnal. 2012; 8: 401-6. (In Russian)
Freeman M. Cerebral palsy. New York: Springer Science 2005; 1055.
Smirnov I.E.,Stepanov A.A., Shakina L.D.,Belyaeva I.A., Bombardirova E.P., Kucherenko A.G. Neurological manifestations of cerebral ischemia in children of the first year of life. Rossiyskiy pediatricheskiy zhurnal. 2016; 19(5): 274-82. (In Russian)
Novak CM, Ozen M, Burd I. Perinatal Brain Injury: Mechanisms, Prevention, and Outcomes. Clin Perinatol. 2018; 45(2): 357-75.
Gosling AS. Recent advances in the neuroimaging and neuropsychology of cerebral palsy. Appl Neuropsychol Child. 2017; 6(1): 55-63.
Choe YR, Kim JS, Kim KH, Yi TI. Relationship Between Functional Level and Muscle Thickness in Young Children With Cerebral Palsy. Ann Rehabil Med. 2018; 42(2): 286-95.
Titarenko N.Yu., Titarenko K.E., Levchenkova V.D., Semenova K.A., Voronov A.V., Dotsenko V.I., Smirnov I.E. Quantitative assessment of motor function disorders in patients with cerebral palsy by video analysis of movements using a two-dimensional biomechanical model. Rossiyskiy pediatricheskiy zhurnal. 2014; 17(5): 20-6. (In Russian)
Davids JR. Management of Neuromuscular Hip Dysplasia in Children With Cerebral Palsy: Lessons and Challenges. J Pediatr Orthop. 2018; 38(Suppl 1): 21-7.
Choi JY, Park ES, Park D, Rha DW. Dynamic spasticity determines hamstring length and knee flexion angle during gait in children with spastic cerebral palsy. Gait Posture. 2018; 64: 255-9.
Franckx H, Hasaerts D, Huysentruyt K, Cools F. Cranial ultrasound and neurophysiological testing to predict neurological outcome in infants born very preterm. Dev Med Child Neurol. 2018. doi: 10.1111/dmcn.13961.
Gilson KM, Davis E, Reddihough D, Graham K, Waters E. Quality of life in children with cerebral palsy: implications for practice. J Child Neurol. 2014;29(8):1134-40.
Jichlinski A, Clarke L, Whitehead MT, Gropman A. «Cerebral Palsy» in a Patient With Arginase Deficiency. Semin Pediatr Neurol. 2018; 26(1): 110-4.
Horn F, Petrík M, Dúbravová D, Hornová J, Brennerová K, Bzduch V. Intrathecal baclofen in mucopolysaccharidosis type II (Hunter syndrome): case report. Childs Nerv Syst. 2018. doi: 10.1007/s00381-018-3857-z.
Gilkes JA, Heldermon CD. Mucopolysaccharidosis III (Sanfilippo Syndrome)- disease presentation and experimental therapies. Pediatr Endocrinol Rev. 2014; 12 (Suppl 1): 133-40.
Takezawa Y, Kikuchi A, Haginoya K, Niihori T, Numata-Uematsu Y, Inui T. et al. Genomic analysis identifies masqueraders of full-term cerebral palsy. Ann Clin Transl Neurol. 2018; 5(5): 538-51.
Khan SA, Mason RW, Giugliani R, Orii K, Fukao T, Suzuki Y et al. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis. Mol Genet Metab. 2018. doi: 10.1016/j.ymgme.2018.04.011.
Nicolas-Jilwan M, AlSayed M. Mucopolysaccharidoses: overview of neuroimaging manifestations. Pediatr Radiol. 2018. doi: 10.1007/s00247-018-4139-3.
Tardieu M, Zérah M, Gougeon ML, Ausseil J, de Bournonville S, Husson B. et al. Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial. Lancet Neurol. 2017; 16(9): 712-20.
Ghosh A, Shapiro E, Rust S, Delaney K, Parker S, Shaywitz AJ et al. Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III. Orphanet J Rare Dis. 2017; 12(1): 117. doi: 10.1186/s13023-017-0675-4.
MacLennan AH, Thompson SC, Gecz J. Cerebral palsy: causes, pathways, and the role of genetic variants. Am J Obstet Gynecol. 2015; 213(6): 779-88.
